Jane Street Group, LLC Fsd Pharma Inc. Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.07 - $1.6 $18,320 - $27,395	17,122 New	17,122 $20,000
Q4 2022 Feb 14, 2023	BUY	$0.73 - $58.49 $5,315 - $425,924	7,282 Added 41.04%	25,024 $19,000
Q3 2022 Nov 14, 2022	BUY	$0.78 - $61.1 $13,838 - $1.08 Million	17,742 New	17,742 $14,000
Q2 2022 Aug 16, 2022	SELL	$0.78 - $1.1 $18,485 - $26,068	-23,699 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$0.82 - $1.1 $11,133 - $14,935	13,578 Added 134.16%	23,699 $21,000
Q4 2021 Feb 15, 2022	BUY	$0.96 - $1.63 $9,716 - $16,497	10,121 New	10,121 $11,000
Q2 2021 Aug 16, 2021	SELL	$1.56 - $2.13 $25,407 - $34,691	-16,287 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$1.65 - $3.87 $26,873 - $63,030	16,287 New	16,287 $31,000

Ticker HUGE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 38,218,100
Market Cap $146M
Description
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.